Figures & data
Figure 1. Screening and identification of peptide candidates for cancer therapy. Different applications of peptides in cancer therapy include vaccines, antibody–drug conjugate, peptide–drug conjugate, cell therapy, and probes for tumor diagnosis and imaging.
![Figure 1. Screening and identification of peptide candidates for cancer therapy. Different applications of peptides in cancer therapy include vaccines, antibody–drug conjugate, peptide–drug conjugate, cell therapy, and probes for tumor diagnosis and imaging.](/cms/asset/0780b0a9-d7bd-403d-a59d-385da6735c30/iemd_a_2218643_f0001_oc.jpg)
Figure 2. Emerging peptides and proteins in ovarian cancer treatment. These targets exhibit diverse origins and functions and could be associated with the testis, placenta, normal adult tissue, tumor stroma, and random unique mutations.
![Figure 2. Emerging peptides and proteins in ovarian cancer treatment. These targets exhibit diverse origins and functions and could be associated with the testis, placenta, normal adult tissue, tumor stroma, and random unique mutations.](/cms/asset/4c103948-9f0f-4f2a-8c51-8cc77b0eb781/iemd_a_2218643_f0002_oc.jpg)
Figure 3. Key requirements for cancer targeting peptides. These criteria were described as important characteristics of peptides/proteins for developing effective immunotherapy.
![Figure 3. Key requirements for cancer targeting peptides. These criteria were described as important characteristics of peptides/proteins for developing effective immunotherapy.](/cms/asset/78ba22ed-7668-4368-a9c6-b3562baed6ed/iemd_a_2218643_f0003_oc.jpg)
Table 1. Competitive environment of emerging peptides for ovarian cancer treatment in phases I, II, and III of development.